Open AccessDirect Treatment Costs of Neovascular Age-related Macular Degeneration and Comparison of Gained and/or Preserved Vision with Expenditure
Author(s) -
Şeyda Yıldırım,
Cezmi Akkın,
Zafer Öztaş,
Serhad Nalçacı,
Filiz Afrashı,
Jale Menteş
Publication year - 2018
Publication title -
turkish journal of ophthalmology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.654
H-Index - 10
eISSN - 2147-2661
pISSN - 1300-0659
DOI - 10.4274/tjo.44370
Subject(s) - medicine , macular degeneration , ophthalmology , visual acuity , ranibizumab , demographics , surgery , optometry , demography , bevacizumab , chemotherapy , sociology
The aim was to quantify the direct medical cost of neovascular age-related macular degeneration (AMD) versus gained or preserved vision.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom